Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

  1. Home

  • Monday, Oct 27th
    4:00 PM – 5:00 PM Central Time
    Cancer Immunotherapy and Its Toxicities, Today and Tomorrow
    Moderator: Jeffrey Sparks, MD, MSc – Brigham and Women's Hospital
    Moderator: Sophia C. Weinmann, MD, FACR – Duke University
    Session Coordinator: Brittany Adler, MD – Johns Hopkins University
  • Monday, Oct 27th
    4:00 PM – 4:30 PM Central Time
    Current Cancer Immunotherapy Landscape and the Future
    Speaker: Aliyah Pabani, MD, MPH – Johns Hopkins
  • Monday, Oct 27th
    4:30 PM – 5:00 PM Central Time
    When Cancer Therapy Triggers Autoimmunity: The Rheumatologist’s Role in Immune Checkpoint Inhibitors Toxicity
    Speaker: Elad Sharon, MD,MPH – Dana-Farber Cancer Institute
  • Tuesday, Oct 28th
    8:30 AM – 9:30 AM Central Time
    The Good, the Bad, and the Ugly: Understanding Mechanisms of Adverse Events After Immune Checkpoint Therapy
    Moderator: Sophia C. Weinmann, MD, FACR – Duke University
    Session Coordinator: Teresa Tarrant, MD – Duke University
  • Tuesday, Oct 28th
    8:30 AM – 8:50 AM Central Time
    Pathogenesis of Immune checkpoint inhibitors-induced myocarditis
    Speaker: Daniela Cihakova, PhD – Johns Hopkins University
  • Tuesday, Oct 28th
    8:50 AM – 9:10 AM Central Time
    Molecular and Immune Hallmarks of Immune-Related Adverse Event Inflammatory Arthritis Induced by Checkpoint Inhibitors
    Speaker: Roza Nurieva, PhD – University of Texas MD Anderson
  • Tuesday, Oct 28th
    9:10 AM – 9:30 AM Central Time
    Mouse Model of Immune-Related Adverse Events
    Speaker: Abby Overacre, PhD – University of Pittsburgh